180 Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,643
Closed -$366K 286
2019
Q3
$366K Sell
3,643
-149
-4% -$14.2K 0.16% 163
2019
Q2
$353K Sell
3,792
-108
-3% -$10.3K 0.16% 159
2019
Q1
$372K Buy
3,900
+741
+23% +$64.8K 0.17% 151
2018
Q4
$283K Hold
3,159
0.13% 190
2018
Q3
$283K Sell
3,159
-126
-4% -$11.1K 0.13% 190
2018
Q2
$261K Buy
3,285
+311
+10% +$25.8K 0.13% 195
2018
Q1
$267K Buy
2,974
+70
+2% +$6.72K 0.14% 185
2017
Q4
$303K Buy
+2,904
New +$328K 0.15% 165

Other funds holding CELG

180 Wealth Advisors's CELG Position: Q4 2019 in Review

180 Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,643 shares — an estimated $366K sold.

180 Wealth Advisors first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $372K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • 180 Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • 180 Wealth Advisors sold 3,643 Celgene Corp shares in Q4 2019, an estimated $366K.
  • 180 Wealth Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • 180 Wealth Advisors's Celgene Corp position peaked at $372K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on 180 Wealth Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.